Optic neuritis in CD59 deficiency: an extremely rare presentation by Çağatay Günay, Elvan Yardım, Elif Yaşar, Ayse Semra Hız-Kurul, Gamze Sarıkaya Uzan, Taylan Öztürk, Aylin Yaman, Uluç Yiş

Subjects: “…complement inhibition…”
Get full text

Individualised therapeutic approach to the patient with atypical haemolytic-uraemic syndrome by Ivana Mikačić, Nikolina Marić

Subjects: Get full text

Targeting the Roots of Kidney Disease: Systematic Review of the Therapies Targeting the Complement System by Maja Roman, Michał Nowicki

Subjects: Get full text

Case Report: Iptacopan in a paroxysmal nocturnal hemoglobinuria patient with severe renal insufficiency by Ting Wu, Xiaoqin Wang

Subjects: Get full text

Case Report: Eculizumab in highly active myasthenia gravis complicated by severe infections by Yufei Deng, Haocheng Luo, Chaoyue Zhang, Li Yang, Shuangshuang Wang, Xuxiang Zhang, Xianni Yan, Xiaojun Yang, Qilong Jiang

Subjects: Get full text

Complement C3 inhibition reduces complement activation in clinical platelet concentrates but does not counteract platelet storage lesions by Linnea I. Andersson, Per Sandgren, Dick J. Sjöström, Camilla Mohlin, Kim Hägerström, Ivar Tjernberg, Tom Eirik Mollnes, Per H. Nilsson

Subjects: Get full text

Complement inhibition rapidly blocks lesion extension and facilitates remyelination in neuromyelitis optica by Katherine S Given, Elizabeth G Acker, Wendy B Macklin, Dan Carlin, Gregory P. Owens, Jeffrey L Bennett

Subjects: Get full text

Characterization of the bispecific VHH antibody tarperprumig (ALXN1820) specific for properdin and designed for low-volume administration by Paul Tamburini, Dennis Vestergaard Pedersen, Denise Devore, Josh Cone, Rekha Patel, Todd Hunter, Fang Sun, Gregers Rom Andersen, Jeffrey Hunter

Subjects: Get full text

Time course of organ and hematological response to complement blockage in transplant-associated thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation by Tatiana A. Rudakova, Julia Yu Vlasova, Olesya V. Paina, Olga A. Slesarchuk, Marina A. Gorodnova, Tatiana S. Schegoleva, Oleg V. Goloshchapov, Tatiana A. Bykova, Elena V. Morozova, Lyudmila S. Zubarovskaya, Ivan S. Moiseev, Alexander D. Kulagin

Subjects: Get full text

Real-World Outcomes with Complement Inhibitors for Geographic Atrophy: A Comparative Study of Pegacetacoplan versus Avacincaptad Pegol by Rush RB, Klein W, Reinauer RM

Subjects: Get full text

Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition by Jessica K. Kaufeld, Lucas Kühne, Ulf Schönermarck, Jan Hinrich Bräsen, Constantin von Kaisenberg, Bodo B. Beck, Florian Erger, Carsten Bergmann, A.N.K.E. von Bergwelt-Baildon, Paul T. Brinkkötter, Linus A. Völker, Jan Menne

Subjects: “…complement inhibition…”
Get full text

Modeling pegcetacoplan treatment effect for atrophic age-related macular degeneration with AI-based progression prediction by Irmela Mantel, Romina M. Lasagni Vitar, Sandro De Zanet

Subjects: Get full text

Real-World Outcomes in Pre-Existing Neovascular Age-Related Macular Degeneration Subjects Undergoing Avacincaptad Therapy for Geographic Atrophy by Rush RB, Klein W, Rush SW, Reinauer RM

Subjects: Get full text

One-Year Outcomes in Subjects Developing Macular Neovascularization While Undergoing Avacincaptad Pegol Therapy for Geographic Atrophy by Rush RB, Klein W, Rush SW, Reinauer R

Subjects: Get full text